XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Stock-Based Compensation, Stock Option Activity (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Assumptions used to estimate the fair values of the stock options granted [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00%    
Additional Disclosures [Abstract]          
Proceeds from stock option exercises     $ 61,725 $ 2,133,396  
Minimum          
Assumptions used to estimate the fair values of the stock options granted [Abstract]          
Risk-free interest rate     0.29%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     5 years 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     39.50%    
Maximum          
Assumptions used to estimate the fair values of the stock options granted [Abstract]          
Risk-free interest rate     1.61%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     6 years 3 months    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     41.50%    
Stock Options and Restricted Stock Awards | Restructuring          
Additional Disclosures [Abstract]          
Stock-based compensation expense     $ 190,000    
Restricted stock awards          
Additional Disclosures [Abstract]          
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $ 578,000   $ 578,000    
Recognized compensation period     1 year    
Restricted stock awards | General and Administrative          
Additional Disclosures [Abstract]          
Stock-based compensation expense $ 178,000 $ 146,000 $ 515,000 146,000  
Stock options          
Stock Options Activity [Roll Forward]          
Outstanding, beginning of period (in shares)     189,187    
Grants (in shares)     202,000    
Exercised (in shares)     (1,500)    
Cancelled (in shares)     (147,500)    
Outstanding, end of period (in shares) 242,187   242,187   189,187
Exercisable, end of period (in shares) 42,687   42,687    
Weighted Average Exercise Price [Roll Forward]          
Outstanding, beginning of period (in dollars per share)     $ 46.79    
Grants (in dollars per share)     61.92    
Exercised (in dollars per share)     41.15    
Cancelled (in dollars per share)     56.51    
Outstanding at end of year (in dollars per share) $ 56.49   56.49   $ 46.79
Exercisable, end of period (in dollars per share) $ 33.45   $ 33.45    
Weighted Average Remaining Contractual Term [Roll Forward]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term     8 years 4 months 6 days   8 years 7 months 13 days
Exercisable     2 years 9 months 7 days    
Aggregate Intrinsic Value [Roll Forward]          
Outstanding, beginning of period     $ 1,920,684    
Outstanding, end of period $ 0   0   $ 1,920,684
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 827,256   $ 827,256    
Additional Disclosures [Abstract]          
Weighted average grant date fair value of stock granted (in dollars per share)     $ 61.92    
Proceeds from stock option exercises     $ 100,000 2,100,000  
Closing price of common stock (in dollars per share) $ 52.83   $ 52.83    
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $ 4,400,000   $ 4,400,000    
Recognized compensation period     8 years 4 months 6 days    
Stock options | General and Administrative          
Additional Disclosures [Abstract]          
Stock-based compensation expense $ 333,000 $ 114,000 $ 469,000 $ 374,000